Carriers of SDHB variants may develop pheochromocytoma, extra-adrenal paraganglioma, and occasionally CBTs, with a metastasis incidence of approximately 23–25%, the highest among all genes associated with paraganglioma [26,37]. This evidence concerns the gene SDHB and paraganglioma.